It is a business services private limited company based in Patna, Bihar, India, established in 2017.
2017 | Patna, Bihar, India | ActiveRbs Drug Formulation Private Limited, a active private limited company, was established on 06 June 2017 in Patna, Bihar, India. Engaging in other services within the business services sector, it holds CIN: U74999BR2017PTC034794. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Rita Sharma (Director), Ravi Raushan Kumar (Director), Saumya Sharma (Director). Past directors included Rakesh Nayan, Saroj Kumar, Ajay Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H/O Of Satyendra Sharma, Road No.-6B Rajendra Nagar, Patna, Bihar, 800016.
U74999BR2017PTC034794
034794
06 June 2017
₹0.50 M
₹0.50 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Rbs Drug Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rita Sharma | Director | 06 Jun 2017 | Current |
| Ravi Raushan Kumar | Director | 23 Mar 2021 | Current |
| Saumya Sharma | Director | 29 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Mar 2021 | Past |
| Pramod Abcsdd | Director | 23 Mar 2021 | Past |
| Pramod Abcsdd | Director | 29 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rbs Drug Formulation Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Rbs Drug Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rbs Drug Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rbs Drug Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rbs Drug Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rbs Drug Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Saumya Sharma was appointed as a Director was appointed as a Director on 29 May 2024 & has been associated with this company since 1 year 6 months . was documented.
The activity Rbs Drug Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was completed.
The activity Ravi Raushan Kumar was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 4 years 8 months . was completed.
Rita Sharma was appointed as a Director was appointed as a Director on 06 Jun 2017 & has been associated with this company since 8 years 5 months . was recorded as a recent event.
Rbs Drug Formulation Private Limited was registered on 06 Jun 2017 with Roc Patna & aged 8 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Rbs Drug Formulation Private Limited is U74999BR2017PTC034794.
Rbs Drug Formulation Private Limited is headquartered at H/O Of Satyendra Sharma, Road No.-6B Rajendra Nagar, Patna, Bihar, 800016.
Rbs Drug Formulation Private Limited was incorporated on 06 June 2017.
The current directors of Rbs Drug Formulation Private Limited are
The primary industry of Rbs Drug Formulation Private Limited is Business Services.
Rbs Drug Formulation Private Limited is unlisted.
The authorized capital of Rbs Drug Formulation Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Rbs Drug Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX